Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
PuraPharm Corp. Ltd. ( (HK:1498) ) has shared an announcement.
PuraPharm Corporation Limited has announced the appointment of Dr. Kam Biu Tsoi as an executive director effective June 30, 2025. Dr. Tsoi, who has over 40 years of experience in sales management and Chinese medicine, will also join the company’s nomination committee. His appointment is expected to strengthen the company’s leadership in the Chinese medicine sector, given his extensive background and previous association with the company.
More about PuraPharm Corp. Ltd.
PuraPharm Corporation Limited is a company involved in the Chinese medicine and healthcare products industry. It focuses on the development, production, and sales of traditional Chinese medicine products.
Average Trading Volume: 117,268
Technical Sentiment Signal: Sell
Current Market Cap: HK$189.6M
For detailed information about 1498 stock, go to TipRanks’ Stock Analysis page.